Surrogate markers of treatment outcome in major depressive disorder
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) is a common medical illness affecting millions worldwide. Despite their widespread use since the 1950s and 1960s, the 'downstream' mechanism by which antidepressants ultimately exert their therapeutic effects remains elusive. In addition, except for a few exceptions such as episode severity and the presence of comorbid Axis-I or Axis-III disorders, biological or clinical characteristics which can accurately quantify the risk of poor treatment outcome are lacking, as are factors which could help patients and clinicians select treatment options that would result in superior outcome. The identification of such markers, termed 'surrogate' markers, could help shed further insights into what constitutes illness and recovery, help identify molecular targets for the development of future antidepressants, and lead the way to the design and refinement of a personalized medicine treatment model for MDD. In the following text, several major areas ('leads') where evidence exists regarding the presence of surrogate markers of efficacy outcome in MDD will be briefly reviewed. Leads include evidence from the role of demographic and clinical factors as surrogate markers, to the role of various biological markers including genotype, brain functional imaging, electroencephalography, dichotic listening, and molecular biology and immunology. The purpose of this work is to focus selectively on areas where there have been findings, as opposed to conducting an exhaustive literature review of studies which have failed to yield any significant breakthrough in our knowledge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115 · cited 1×
“Mayberg et al. (2000), for example, reported a correlation between an increase in brainstem and dorsal cortical metabolism (prefrontal, parietal, anterior cingulate, posterior cingulate), or a decrease in limbic and striatum metabolism (subgenual cingulate, hippocampus, insula, palladium) as…”
BackgroundFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Fu, C. H. Y., Williams, S. C. R., Cleare, A. J., Brammer, M. J., Walsh, N. D., Kim, J., Andrew, C. M., Pich, E. M., Williams, P. M., Reed, L. J., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.877 · Cited by 775
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529 · cited 1×
“…and treatment outcome in MDD, with a number of pooled meta-analyses confirming a by guest on June 8, 2016 http://ijnp.oxfordjournals.org/ D ow nloaded from predictive role, more so for Caucasian than Asian patients (Kato & Serretti, 2010 ; Serretti et al. 2006, 2007 ; Smits et al. 2004).”
BackgroundHegerl, U., & Juckel, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90137-3 · Cited by 472 · cited 1×
“…suggests that evoked potentials following such a stimulus are dependent on the loudness of the stimulus, while a ‘weak’ LDAEP suggests by guest on June 8, 2016 http://ijnp.oxfordjournals.org/ D ow nloaded from the readings are not very dependent on the loudness of the sound (Hegerl & Juckel, 1993).”
BackgroundReview and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450 · cited 2×
“Subsequently, however, Kraft et al. (2007) and Hu et al.”
BackgroundTaylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1217 · Cited by 406 · cited 2×
“…been found to serve as both a predictor (temporally preceding outcome) and mediator (indicating a relationship between change in value during the course of therapy and outcome at endpoint) of outcome (Baldwin et al. 2009; Nierenberg et al. 1995, 2000; Stassen et al. 1996; Taylor et al. 2006a, b).”
BackgroundChen, C.-H., Ridler, K., Suckling, J., Williams, S., Fu, C. H. Y., Merlo-Pich, E., & Bullmore, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.018 · Cited by 354 · cited 2×
“metabolism in the anterior cingulate cortex following the presentation of visual or auditory stimuli designed to induce affect (either happy or sad) at baseline and symptom improvement during antidepressant and/or psychotherapy treatment (Chen et al. 2007; Davidson et al. 2003; Fu et al. 2004, 2007, 2008).”
BackgroundFu, C. H. Y., Williams, S. C. R., Cleare, A. J., Scott, J., Mitterschiffthaler, M. T., Walsh, N. D., Donaldson, C., Suckling, J., Andrew, C., Steiner, H., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.033 · Cited by 349 · cited 1×
“…in the anterior cingulate cortex following the presentation of visual or auditory stimuli designed to induce affect (either happy or sad) at baseline and symptom improvement during antidepressant and/or psychotherapy treatment (Chen et al. 2007; Davidson et al. 2003; Fu et al. 2004, 2007, 2008).”
Background
Cited by
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Lanzenberger, R., Kranz, G. S., Haeusler, D., Akimova, E., Savli, M., Hahn, A., Mitterhauser, M., Spindelegger, C., Philippe, C., Fink, M., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.023 · Cited by 139
Wagner, S., Engel, A., Engelmann, J., Herzog, D., Dreimüller, N., Müller, M. B., Tadić, A., & Lieb, K. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.003 · Cited by 73
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants
Niciu, M. J., Mathews, D. C., Nugent, A. C., Ionescu, D. F., Furey, M. L., Richards, E. M., Machado-Vieira, R., & Zarate, C. A. (2014) · Depression and Anxiety · doi:10.1002/da.22224 · Cited by 45
Xie, Z., Gu, W., & Ming, T. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220404123433 · Cited by 6
Metadata
- Authors
- Papakostas, G. I.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-04
- Volume
- 15
- Issue
- 06
- Pages
- 841-854
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2095821590
- Cited by
- 28
- References
- 22
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.